Cargando…

Can Cisplatin Therapy Be Improved? Pathways That Can Be Targeted

Cisplatin (cis-diamminedichloroplatinum (II)) is the oldest known chemotherapeutic agent. Since the identification of its anti-tumour activity, it earned a remarkable place as a treatment of choice for several cancer types. It remains effective against testicular, bladder, lung, head and neck, ovari...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ali, Reem, Aouida, Mustapha, Alhaj Sulaiman, Abdallah, Madhusudan, Srinivasan, Ramotar, Dindial
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266583/ https://www.ncbi.nlm.nih.gov/pubmed/35806243 http://dx.doi.org/10.3390/ijms23137241

Ejemplares similares

The histone H2B Arg95 residue links the pheromone response pathway to rapamycin-induced G(1) arrest in yeast
por: Alhaj Sulaiman, Abdallah, et al.
Publicado: (2022)

The Yeast Permease Agp2 Senses Cycloheximide and Undergoes Degradation That Requires the Small Protein Brp1-Cellular Fate of Agp2 in Response to Cycloheximide
por: Mohanty, Ashima, et al.
Publicado: (2023)

The histone H2B Arg95 residue efficiently recruits the transcription factor Spt16 to mediate Ste5 expression of the pheromone response pathway
por: Sulaiman, Abdallah Alhaj, et al.
Publicado: (2023)

A simple protocol to isolate a single human cell PRDX1 knockout generated by CRISPR-Cas9 system
por: Aouida, Mustapha, et al.
Publicado: (2022)

Yeast Lacking the PP2A Phosphatase Regulatory Subunit Rts1 Sensitizes rad51 Mutants to Specific DNA Damaging Agents
por: Aouida, Mustapha, et al.
Publicado: (2019)

CRISPR FokI Dead Cas9 System: Principles and Applications in Genome Engineering
por: Saifaldeen, Maryam, et al.
Publicado: (2020)

Agp2, a Member of the Yeast Amino Acid Permease Family, Positively Regulates Polyamine Transport at the Transcriptional Level
por: Aouida, Mustapha, et al.
Publicado: (2013)

Correction: Agp2, a Member of the Yeast Amino Acid Permease Family, Positively Regulates Polyamine Transport at the Transcriptional Level
por: Aouida, Mustapha, et al.
Publicado: (2013)

A CRISPR-based approach using dead Cas9-sgRNA to detect SARS-CoV-2
por: Aouida, Mustapha, et al.
Publicado: (2023)

The Base Excision Repair Pathway in the Nematode Caenorhabditis elegans
por: Elsakrmy, Noha, et al.
Publicado: (2020)

A novel approach using C. elegans DNA damage-induced apoptosis to characterize the dynamics of uptake transporters for therapeutic drug discoveries
por: Papaluca, Arturo, et al.
Publicado: (2016)

Complementation of the Yeast Model System Reveals that Caenorhabditis elegans OCT-1 Is a Functional Transporter of Anthracyclines
por: Brosseau, Nicolas, et al.
Publicado: (2015)

Rrd1 isomerizes RNA polymerase II in response to rapamycin
por: Jouvet, Nathalie, et al.
Publicado: (2010)

UNG-1 and APN-1 are the major enzymes to efficiently repair 5-hydroxymethyluracil DNA lesions in C. elegans
por: Papaluca, Arturo, et al.
Publicado: (2018)

The human organic cation transporter OCT1 mediates high affinity uptake of the anticancer drug daunorubicin
por: Andreev, Emil, et al.
Publicado: (2016)

CRISPR/Cas9-mediated target validation of the splicing inhibitor Pladienolide B
por: Aouida, Mustapha, et al.
Publicado: (2016)

Can Metabolic Pathways Be Therapeutic Targets in Rheumatoid Arthritis?
por: Sanchez-Lopez, Elsa, et al.
Publicado: (2019)

Tissue-Specific Delivery of CRISPR Therapeutics: Strategies and Mechanisms of Non-Viral Vectors
por: Shalaby, Karim, et al.
Publicado: (2020)

DNA repair in cancer: emerging targets for personalized therapy
por: Abbotts, Rachel, et al.
Publicado: (2014)

Targeting the Phosphatidylinositol-3-kinase Pathway in Gastric Cancer: Can Omics Improve Outcomes?
por: Tran, Phu, et al.
Publicado: (2016)

ETS-targeted therapy: can it substitute for MEK inhibitors?
por: Tetsu, Osamu, et al.
Publicado: (2017)

Can Pediatric Heart Failure Therapy Be Improved? Yes It Can, But…
por: Schranz, Dietmar
Publicado: (2022)

Can follicular helper T cells be targeted to improve vaccine efficacy?
por: Linterman, Michelle A., et al.
Publicado: (2016)

The Peptidyl Prolyl Isomerase Rrd1 Regulates the Elongation of RNA Polymerase II during Transcriptional Stresses
por: Poschmann, Jeremie, et al.
Publicado: (2011)

Can pharmacogenetics explain efficacy and safety of cisplatin pharmacotherapy?
por: Roco, Ángela, et al.
Publicado: (2014)

Can Newer Anti-Diabetic Therapies Delay the Development of Diabetic Nephropathy?
por: Aziz, Sohail, et al.
Publicado: (2021)

Can Stemness and Chemoresistance Be Therapeutically Targeted via Signaling Pathways in Ovarian Cancer?
por: Roy, Lynn, et al.
Publicado: (2018)

Cisplatin-incorporating polymeric micelles (NC-6004) can reduce nephrotoxicity and neurotoxicity of cisplatin in rats
por: Uchino, H, et al.
Publicado: (2005)

Can pycnogenol prevent cisplatin-induced damage in uterus and ovaries?
por: Turkler, Can, et al.
Publicado: (2019)

Peroxiredoxin 1 interacts with and blocks the redox factor APE1 from activating interleukin-8 expression
por: Nassour, Hassan, et al.
Publicado: (2016)

Gene Therapy - Can it Cure Type 1 Diabetes?
por: Srinivasan, Mirra, et al.
Publicado: (2021)

Oligometastasis in Prostate Cancer: Can We Learn from Those “Excluded” from a Phase 2 Trial?
por: Glicksman, Rachel M., et al.
Publicado: (2023)

Can Social Functioning in Schizophrenia Be Improved through Targeted Social Cognitive Intervention?
por: Roberts, David L., et al.
Publicado: (2012)

Tackling cisplatin resistance in ovarian cancer: what can we do?
por: Perego, Paola
Publicado: (2021)

Can We Design a Nogo Receptor-Dependent Cellular Therapy to Target MS?
por: Kim, Min Joung, et al.
Publicado: (2018)

Can Artificial Intelligence Improve the Management of Pneumonia
por: Chumbita, Mariana, et al.
Publicado: (2020)

How can developing countries harness biotechnology to improve health?
por: Daar, Abdallah S, et al.
Publicado: (2007)

Oxidative Stress: What Is It? Can It Be Measured? Where Is It Located? Can It Be Good or Bad? Can It Be Prevented? Can It Be Cured?
por: Azzi, Angelo
Publicado: (2022)

Lipid-lowering therapy: who can benefit?
por: Lewis, Sandra J
Publicado: (2011)

How nanotechnology can enhance docetaxel therapy
por: Zhang, Li, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_lss3up0vuv4oi86rlq5dq7am35